Strides Arcolab is currently trading at Rs. 731.90, up by 13.25 points or 1.84% from its previous closing of Rs. 718.65 on the BSE.
The scrip opened at Rs. 732.95 and has touched a high and low of Rs. 761.00 and Rs. 721.50 respectively. So far 178727 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 776.90 on 20-Jun-2012 and a 52 week low of Rs. 276.25 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 776.90 and Rs. 714.00 respectively. The current market cap of the company is Rs. 4271.71 crore.
The promoters holding in the company stood at 28.35% while Institutions and Non-Institutions held 55.55% and 16.11% respectively.
Strides Arcolabs has redeemed the outstanding $80 million FCCBs on due date. In the year 2007, the company had originally raised $1000 million FCCBs and in 2009 had bought back $20 million. It had paid $116 million for redeeming the outstanding bonds including the redemption premium of 45.058%.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1517.90 |
Dr. Reddys Lab | 6362.00 |
Cipla | 1478.90 |
Zydus Lifesciences | 1066.95 |
Lupin | 1614.95 |
View more.. |